News

The Department of Health and Human Services said it is winding down its mRNA vaccine-development activities under the ...
The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under ...
The nation's top medical organizations are speaking out after U.S. health officials told them they will no longer help ...
For the past decade, Sughra Ayaz has traveled door to door in southeastern Pakistan, pleading with parents to allow children ...
A vaccine rates have declined in the U.S., there have been notable increases in several diseases, including measles and ...
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...